A Distal Locus Element Mediates IFN-γ Priming of Lipopolysaccharide-Stimulated TNF Gene Expression

Cell Reports

Volumn 9, Issue 5, 2014, Pages 1718-1728

  Chow, Nancy A ^a   Jasenosky, Luke D ^a   Goldfeld, Anne E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; HISTONE; IRF1 PROTEIN, HUMAN; PROTEIN BINDING; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENE LOCUS; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN DOMAIN; RNA SYNTHESIS; TNF GENE; TRANSCRIPTION INITIATION SITE; ACETYLATION; CELL LINE; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN PROCESSING; TRANSCRIPTION INITIATION; UPREGULATION;

ACETYLATION; BASE SEQUENCE; CELL LINE; CONSERVED SEQUENCE; GENE EXPRESSION; GENETIC LOCI; HISTONES; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84915805486     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.11.011     Document Type: Article

References (41)

1. Baena A., Mootnick A.R., Falvo J.V., Tsytskova A.V., Ligeiro F., Diop O.M., Brieva C., Gagneux P., O'Brien S.J., Ryder O.A., Goldfeld A.E. Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity. PLoS ONE 2007, 2:e621.
2. Barthel R., Goldfeld A.E. T cell-specific expression of the human TNF-alpha gene involves a functional and highly conserved chromatin signature in intron 3. J.Immunol. 2003, 171:3612-3619.
3. Biglione S., Tsytsykova A.V., Goldfeld A.E. Monocyte-specific accessibility of a matrix attachment region in the tumor necrosis factor locus. J.Biol. Chem. 2011, 286:44126-44133.
4. Calo E., Wysocka J. Modification of enhancer chromatin: what, how, and why?. Mol. Cell 2013, 49:825-837.
5. Cotney J., Leng J., Oh S., DeMare L.E., Reilly S.K., Gerstein M.B., Noonan J.P. Chromatin state signatures associated with tissue-specific gene expression and enhancer activity in the embryonic limb. Genome Res. 2012, 22:1069-1080.
6. Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., Hanna J., Lodato M.A., Frampton G.M., Sharp P.A., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 2010, 107:21931-21936.
7. Falvo J.V., Brinkman B.M., Tsytsykova A.V., Tsai E.Y., Yao T.P., Kung A.L., Goldfeld A.E. A stimulus-specific role for CREB-binding protein (CBP) in Tcell receptor-activated tumor necrosis factor alpha gene expression. Proc. Natl. Acad. Sci. USA 2000, 97:3925-3929.
8. Falvo J.V., Uglialoro A.M., Brinkman B.M., Merika M., Parekh B.S., Tsai E.Y., King H.C., Morielli A.D., Peralta E.G., Maniatis T., et al. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol. Cell. Biol. 2000, 20:2239-2247.
9. Falvo J.V., Tsytsykova A.V., Goldfeld A.E. Transcriptional control of the TNF gene. Curr. Dir. Autoimmun. 2010, 11:27-60.
10. Gilbert L.A., Larson M.H., Morsut L., Liu Z., Brar G.A., Torres S.E., Stern-Ginossar N., Brandman O., Whitehead E.H., Doudna J.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-451.
11. Goldfeld A.E., Maniatis T. Coordinate viral induction of tumor necrosis factor alpha and interferon beta in human B cells and monocytes. Proc. Natl. Acad. Sci. USA 1989, 86:1490-1494.
12. Goldfeld A.E., Doyle C., Maniatis T. Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 1990, 87:9769-9773.
13. Goldfeld A.E., McCaffrey P.G., Strominger J.L., Rao A. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J.Exp. Med. 1993, 178:1365-1379.
14. Hayes M.P., Zoon K.C. Priming of human monocytes for enhanced lipopolysaccharide responses: expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor. Infect. Immun. 1993, 61:3222-3227.
15. Jiao A.L., Slack F.J. RNA-mediated gene activation. Epigenetics 2014, 9:27-36.
16. Leung J.Y., McKenzie F.E., Uglialoro A.M., Flores-Villanueva P.O., Sorkin B.C., Yunis E.J., Hartl D.L., Goldfeld A.E. Identification of phylogenetic footprints in primate tumor necrosis factor-alpha promoters. Proc. Natl. Acad. Sci. USA 2000, 97:6614-6618.
17. Liu J., Cao S., Herman L.M., Ma X. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J.Exp. Med. 2003, 198:1265-1276.
18. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., Russell S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J.Biol. Chem. 1993, 268:1908-1913.
19. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., Dzialo R., Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J.Exp. Med. 1996, 183:147-157.
20. Margolin J.F., Friedman J.R., Meyer W.K., Vissing H., Thiesen H.J., Rauscher F.J. Krüppel-associated boxes are potent transcriptional repression domains. Proc. Natl. Acad. Sci. USA 1994, 91:4509-4513.
21. Marsili G., Remoli A.L., Sgarbanti M., Battistini A. Role of acetylases and deacetylase inhibitors in IRF-1-mediated HIV-1 long terminal repeat transcription. Ann. N Y Acad. Sci. 2004, 1030:636-643.
22. Masumi A., Wang I.M., Lefebvre B., Yang X.J., Nakatani Y., Ozato K. The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol. Cell. Biol. 1999, 19:1810-1820.
23. Murray H.W. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann. Intern. Med. 1988, 108:595-608.
24. Pace J.L., Russell S.W., Torres B.A., Johnson H.M., Gray P.W. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J.Immunol. 1983, 130:2011-2013.
25. Pine R., Decker T., Kessler D.S., Levy D.E., Darnell J.E. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 1990, 10:2448-2457.
26. Qi L.S., Larson M.H., Gilbert L.A., Doudna J.A., Weissman J.S., Arkin A.P., Lim W.A. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013, 152:1173-1183.
27. Qiao Y., Giannopoulou E.G., Chan C.H., Park S.H., Gong S., Chen J., Hu X., Elemento O., Ivashkiv L.B. Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling. Immunity 2013, 39:454-469.
28. Rada-Iglesias A., Bajpai R., Swigut T., Brugmann S.A., Flynn R.A., Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470:279-283.
29. Reinke H., Hörz W. Anatomy of a hypersensitive site. Biochim. Biophys. Acta 2004, 1677:24-29.
30. Sanceau J., Wijdenes J., Revel M., Wietzerbin J. IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. J.Immunol. 1991, 147:2630-2637.
31. Sancéau J., Kaisho T., Hirano T., Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J.Biol. Chem. 1995, 270:27920-27931.
32. Shalem O., Sanjana N.E., Hartenian E., Shi X., Scott D.A., Mikkelsen T.S., Heckl D., Ebert B.L., Root D.E., Doench J.G., Zhang F. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 2014, 343:84-87.
33. Tamura T., Yanai H., Savitsky D., Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 2008, 26:535-584.
34. Taylor J.M., Wicks K., Vandiedonck C., Knight J.C. Chromatin profiling across the human tumour necrosis factor gene locus reveals a complex, cell type-specific landscape with novel regulatory elements. Nucleic Acids Res. 2008, 36:4845-4862.
35. Thurman R.E., Rynes E., Humbert R., Vierstra J., Maurano M.T., Haugen E., Sheffield N.C., Stergachis A.B., Wang H., Vernot B., et al. The accessible chromatin landscape of the human genome. Nature 2012, 489:75-82.
36. Tsai E.Y., Falvo J.V., Tsytsykova A.V., Barczak A.K., Reimold A.M., Glimcher L.H., Fenton M.J., Gordon D.C., Dunn I.F., Goldfeld A.E. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter invivo. Mol. Cell. Biol. 2000, 20:6084-6094.
37. Tsytsykova A.V., Goldfeld A.E. Nuclear factor of activated Tcells transcription factor NFATp controls superantigen-induced lethal shock. J.Exp. Med. 2000, 192:581-586.
38. Tsytsykova A.V., Goldfeld A.E. Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes. Mol. Cell. Biol. 2002, 22:2620-2631.
39. Tsytsykova A.V., Rajsbaum R., Falvo J.V., Ligeiro F., Neely S.R., Goldfeld A.E. Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers. Proc. Natl. Acad. Sci. USA 2007, 104:16850-16855.
40. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
41. Zentner G.E., Tesar P.J., Scacheri P.C. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res. 2011, 21:1273-1283.